Evidence map›Paper›PMID 32571361›Full record

ArticleTheoretical biology & medical modelling2020

Modelling HIV disease process and progression in seroconversion among South Africa women: using transition-specific parametric multi-state model.

Zelalem G Dessie, Temesgen Zewotir, Henry Mwambi, Delia North

Abstract read
In one paragraph

Article in Theoretical biology & medical modelling, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zelalem G DessieSchool of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Durban, South Africa. zelalem_getahune@yahoo.com.
Temesgen ZewotirSchool of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Durban, South Africa.
Henry MwambiSchool of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Durban, South Africa.
Delia NorthSchool of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Durban, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHIV infected patients may experience many intermediate events including between-event transition throughout their follow up. Through modelling these transitions, we can gain a deeper understanding of HIV disease process and progression and of factors that influence the disease process and progression pathway. In this work, we present transition-specific parametric multi-state models to describe HIV disease process and progression.

methodsThe data is from an ongoing prospective cohort study conducted amongst adult women who were HIV-infected in KwaZulu-Natal, South Africa. Participants were enrolled during the acute HIV infection phase and then followed up during chronic infection, up to ART initiation.

resultsTransition specific distributions for multi-state models, including a variety of accelerated failure time (AFT) models and proportional hazards (PH) models, were presented and compared in this study. The analysis revealed that women enrolling with a CD4 count less than 350 cells/mm

conclusionMulti-state modelling of transition-specific distributions offers a flexible tool for the study of demographic and clinical characteristics' effects on the entire disease progression pathway. It is hoped that the article will help applied researchers to familiarize themselves with the models, including interpretation of results.

Indexed as

HIV InfectionsSeroconversionAdultCD4 Lymphocyte CountDisease ProgressionFemaleHumansLongitudinal StudiesProbabilityProspective StudiesSexual PartnersSouth AfricaViral LoadAFT modelsFactor analysisLatent variablesMarkov modelTransitions and quality of life domain scoresWaiting probabilities

Identifiers

PMID32571361
PMCPMC7310520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.